Compare RDWR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDWR | CERT |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2000 | 2020 |
| Metric | RDWR | CERT |
|---|---|---|
| Price | $32.58 | $11.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 13 |
| Target Price | ★ $41.50 | $12.68 |
| AVG Volume (30 Days) | 393.3K | ★ 2.5M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $11.14 | N/A |
| Revenue Next Year | $9.05 | $3.64 |
| P/E Ratio | $59.76 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $21.75 | $4.45 |
| 52 Week High | $38.50 | $12.61 |
| Indicator | RDWR | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 54.05 |
| Support Level | $26.53 | $6.26 |
| Resistance Level | $38.50 | $11.73 |
| Average True Range (ATR) | 1.66 | 0.60 |
| MACD | -0.19 | -0.13 |
| Stochastic Oscillator | 49.96 | 33.03 |
Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.